XM does not provide services to residents of the United States of America.
A
A

Aviva

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

StanChart lifts FTSE 100 but fails to avert weekly losses

UPDATE 2-StanChart lifts FTSE 100 but fails to avert weekly losses For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Standard Chartered rises on share buyback, profit rise British consumer confidence falls in February FTSE 100 up 0.3%, FTSE 250 off 0.4% Updated at 1658 GMT By Shristi Achar A Feb 23 (Reuters) - Britain's FTSE 100 closed higher Friday, with Standard Chartered in the lead after it announced bumper investor payouts, though wee
A
E
S
N
U

Bechtle, Schneider Electric, Sobi

EUROPE RESEARCH ROUNDUP-Bechtle, Schneider Electric, Sobi Feb 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bechtle, Schneider Electric and Sobi on Thursday. HIGHLIGHTS * Bechtle AG BC8G.DE : Berenberg raises to buy from hold; raises PT to EUR 57 from EUR 41 * Moneysupermarket.com MONY.L : Berenberg raises to buy from hold * Saab AB SAABb.ST : Citigroup cuts to neutral from buy * Schneider Electric SCHN.PA : HSBC cuts to hold
A
B
B
B
C
E
F
G
H
H
H
I
I
L
L
P
S
S
U
W
A
A
A
B
B
B
E
F
R
S
W

UK equities rise on inflation relief

UPDATE 2-UK equities rise on inflation relief For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window British consumer prices unchanged in January Coca-Cola HBC posts record annual profit TUI drops as shareholders approve leaving LSE FTSE 100 up 0.8%, FTSE 250 adds 0.4% Updated at 1654 GMT By Shristi Achar A and Sruthi Shankar Feb 14 (Reuters) - The UK's main stock indexes rose on Wednesday after softer-than-expected inflation data provided comf
A
E
G
A
N
U

FTSE 100 retreats as AstraZeneca earnings disappoint

UPDATE 2-FTSE 100 retreats as AstraZeneca earnings disappoint For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window AstraZeneca falls on Q4 profit miss BAT rallies on ITC stake sale Unilever climbs on share buyback, higher Q4 sales FTSE 100 down 0.4%, FTSE 250 flat Updated at 1704 GMT By Khushi Singh and Sruthi Shankar Feb 8 (Reuters) - Early gains in the UK's blue-chip stock index fizzled out on Thursday after drugmaker AstraZeneca fell more
A
A
B
M
A
N
U

Upbeat earnings spark a rise in UK equities

Upbeat earnings spark a rise in UK equities For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window FTSE 100 up 0.2%, FTSE 250 adds 0.4% Feb 8 (Reuters) - Britain's benchmark FTSE 100 rose on Thursday, supported by a string of upbeat results from industry giants including Unilever and British American Tobacco, while industrial metal miners climbed on a softer dollar.
A
B
N
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.